4.57
Atai Life Sciences N V (ATAI) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
53.76%
0.719
|
1.555 | -0.005 | 0.04 | 0.273 |
Operating Expenses |
18.55%
25.99
|
21.93 | 30.26 | 22.64 | 26.00 |
Benefits Costs and Expenses |
1.82%
28.37
|
27.86 | 39.18 | 26.50 | 57.35 |
Costs And Expenses |
1.82%
28.37
|
27.86 | 39.18 | 26.50 | 57.35 |
Operating Income/Loss |
24.07%
-25.27
|
-20.37 | -30.27 | -22.60 | -25.73 |
Nonoperating Income/Loss |
59.93%
-2.38
|
-5.939 | -8.919 | -3.861 | -31.35 |
Income/Loss Before Equity Method Investments |
5.11%
-27.65
|
-26.31 | -39.18 | -26.46 | -57.08 |
Income/Loss From Equity Method Investments |
-
|
- | - | -0.026 | -0.273 |
Income/Loss From Continuing Operations Before Tax |
5.11%
-27.65
|
-26.31 | -39.18 | -26.46 | -57.08 |
Income Tax Expense/Benefit, Current |
0.00%
0.10
|
0.10 | - | - | - |
Income Tax Expense/Benefit |
40.38%
0.093
|
0.156 | -0.193 | -0.178 | 0.019 |
Income/Loss From Continuing Operations After Tax |
4.84%
-27.75
|
-26.46 | -38.99 | -26.29 | -57.10 |
|
4.84%
-27.75
|
-26.46 | -38.99 | -26.31 | -57.37 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
50.00%
-0.017
|
-0.034 | -0.033 | -0.025 | -0.057 |
Basic Average Shares |
11.51%
196.56
|
176.27 | 0.1868 | 160.62 | 160.39 |
Diluted Average Shares |
11.51%
196.56
|
176.27 | 0.1868 | 160.62 | 160.39 |
Basic Earnings Per Share |
6.67%
-0.14
|
-0.15 | -0.24 | -0.16 | -0.36 |
Diluted Earnings Per Share |
6.67%
-0.14
|
-0.15 | -0.24 | -0.16 | -0.36 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):